{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:59Z","timestamp":1794047459555,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>ETV6::ACSL6 represents a rare genetic aberration in hematopoietic neoplasms and is often associated with severe eosinophilia, which confers an unfavorable prognosis requiring additional anti-inflammatory treatment. However, since the translocation is unlikely to produce a fusion protein, the mechanism of ETV6::ACSL6 action remains unclear. Here, we performed multi-omics analyses of primary leukemia cells and patient-derived xenografts from an acute lymphoblastic leukemia (ALL) patient with ETV6::ACSL6 translocation. We identified a super-enhancer located within the ETV6 gene locus, and revealed translocation and activation of the super-enhancer associated with the ETV6::ACSL6 fusion. The translocated super-enhancer exhibited intense interactions with genomic regions adjacent to and distal from the breakpoint at chromosomes 5 and 12, including genes coding inflammatory factors such as IL-3. This led to modulations in DNA methylation, histone modifications, and chromatin structures, triggering transcription of inflammatory factors leading to eosinophilia. Furthermore, the bromodomain and extraterminal domain (BET) inhibitor synergized with standard-of-care drugs for ALL, effectively reducing IL-3 expression and inhibiting ETV6::ACSL6 ALL growth in vitro and in vivo. Overall, our study revealed for the first time a cis-regulatory mechanism of super-enhancer translocation in ETV6::ACSL6ALL, leading to an ALL-accompanying clinical syndrome. These findings may stimulate novel treatment approaches for this challenging ALL subtype.<\/jats:p>","DOI":"10.3324\/haematol.2023.284121","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T03:26:51Z","timestamp":1707967611000},"page":"2445-2458","source":"Crossref","is-referenced-by-count":11,"title":["&lt;i&gt;ETV6::ACSL6&lt;\/i&gt; translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression"],"prefix":"10.3324","volume":"109","author":[{"given":"Wenqian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liquan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjeong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duohui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"64144","doi-asserted-by":"crossref","unstructured":"Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007; 7(4):233-245.","DOI":"10.1038\/nrc2091"},{"key":"64145","unstructured":"Li JF, Dai YT, Lilljebj\u00f6rn H. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A. 2018; 115(50):E11711-E11720."},{"key":"64146","doi-asserted-by":"crossref","unstructured":"Chen B, Jiang L, Zhong ML. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2018; 115(2):373-378.","DOI":"10.1073\/pnas.1717125115"},{"key":"64147","doi-asserted-by":"crossref","unstructured":"Rasighaemi P, Ward AC. ETV6 and ETV7: siblings in hematopoiesis and its disruption in disease. Crit Rev Oncol Hematol. 2017; 116(2):106-115.","DOI":"10.1016\/j.critrevonc.2017.05.011"},{"key":"64148","doi-asserted-by":"crossref","unstructured":"Zaliova M, Moorman AV, Cazzaniga G. Characterization of leukemias with ETV6-ABL1 fusion. Haematologica. 2016; 101(9):1082-1093.","DOI":"10.3324\/haematol.2016.144345"},{"key":"64149","doi-asserted-by":"crossref","unstructured":"Zhou MH, Gao L, Jing Y. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia. Ann Hematol. 2012; 91(8):1235-1243.","DOI":"10.1007\/s00277-012-1431-4"},{"key":"64150","doi-asserted-by":"crossref","unstructured":"Bain BJ, Ahmad S. Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?. Br J Haematol. 2014; 166(6):809-817.","DOI":"10.1111\/bjh.12963"},{"key":"64151","doi-asserted-by":"crossref","unstructured":"Zimmermannova O, Doktorova E, Stuchly J. An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia. Oncogene. 2017; 36(43):5985-5994.","DOI":"10.1038\/onc.2017.210"},{"key":"64152","doi-asserted-by":"crossref","unstructured":"Su Z, Liu X, Hu W. Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features. Hematology. 2022; 27(1):1010-1018.","DOI":"10.1080\/16078454.2022.2117206"},{"key":"64153","doi-asserted-by":"crossref","unstructured":"Cools J, Mentens N, Odero MD. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12) (q31;p13). Blood. 2002; 99(5):1776-1784.","DOI":"10.1182\/blood.V99.5.1776"},{"key":"64154","doi-asserted-by":"crossref","unstructured":"Esnault S, Kelly EA. Essential mechanisms of differential activation of eosinophils by IL-3 compared to GM-CSF and IL-5. Crit Rev Immunol. 2016; 36(5):429-444.","DOI":"10.1615\/CritRevImmunol.2017020172"},{"key":"64155","doi-asserted-by":"crossref","unstructured":"Patel B, Kang Y, Cui K. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia. Leukemia. 2014; 28(2):349-361.","DOI":"10.1038\/leu.2013.158"},{"key":"64156","doi-asserted-by":"crossref","unstructured":"Huang Y, Mouttet B, Warnatz HJ. The leukemogenic TCF3-HLF complex rewires enhancers driving cellular identity and self-renewal conferring EP300 vulnerability. Cancer Cell. 2019; 36(6):630-644.","DOI":"10.1016\/j.ccell.2019.10.004"},{"key":"64157","doi-asserted-by":"crossref","unstructured":"Polak R, Bierings MB, van der Leije CS. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Haematologica. 2019; 104(4):738-748.","DOI":"10.3324\/haematol.2018.193631"},{"key":"64158","doi-asserted-by":"crossref","unstructured":"Adnan-Awad S, Kim D, Hohtari H. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia. 2021; 35(7):1964-1975.","DOI":"10.1038\/s41375-020-01082-4"},{"key":"64159","doi-asserted-by":"crossref","unstructured":"Yagasaki F, Jinnai I, Yoshida S. Fusion of TEL\/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13). Genes Chromosomes Cancer. 1999; 26(3):192-202.","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<192::AID-GCC2>3.0.CO;2-E"},{"key":"64160","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC. Burkitt lymphoma. Nat Rev Dis Primers. 2022; 8(1):78.","DOI":"10.1038\/s41572-022-00404-3"},{"key":"64161","doi-asserted-by":"crossref","unstructured":"Rawat VP, Cusan M, Deshpande A. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci U S A. 2004; 101(3):817-822.","DOI":"10.1073\/pnas.0305555101"},{"key":"64162","doi-asserted-by":"crossref","unstructured":"Riedel SS, Lu C, Xie HM. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. Mol Cell. 2021; 81(11):2332-2348.","DOI":"10.1016\/j.molcel.2021.04.014"},{"key":"64163","doi-asserted-by":"crossref","unstructured":"Argelaguet R, Clark SJ, Mohammed H. Multi-omics profiling of mouse gastrulation at single-cell resolution. Nature. 2019; 576(7787):487-491.","DOI":"10.1038\/s41586-019-1825-8"},{"key":"64164","doi-asserted-by":"crossref","unstructured":"Clark SJ, Smallwood SA, Lee HJ, Krueger F, Reik W, Kelsey G. Genome-wide base-resolution mapping of DNA methylation in single cells using single-cell bisulfite sequencing (scBS-seq). Nat Protoc. 2017; 12(3):534-547.","DOI":"10.1038\/nprot.2016.187"},{"key":"64165","doi-asserted-by":"crossref","unstructured":"Jing D, Huang Y, Liu X. Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia. Cancer Cell. 2018; 34(6):906-921.","DOI":"10.1016\/j.ccell.2018.11.002"},{"key":"64166","doi-asserted-by":"crossref","unstructured":"Yu CH, Wu G, Chang CC. Sequential approach to improve the molecular classification of childhood acute lymphoblastic leukemia. J Mol Diagn. 2022; 24(11):1195-1206.","DOI":"10.1016\/j.jmoldx.2022.08.001"},{"key":"64167","doi-asserted-by":"crossref","unstructured":"Fang F, Lu J, Sang X. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia. J Exp Clin Cancer Res. 2022; 41(1):225.","DOI":"10.1186\/s13046-022-02428-9"},{"key":"64168","doi-asserted-by":"crossref","unstructured":"Han C, Khodadadi-Jamayran A, Lorch AH. SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia. Sci Adv. 2022; 8(3):eabj8357.","DOI":"10.1126\/sciadv.abj8357"},{"key":"64169","doi-asserted-by":"crossref","unstructured":"Zhu J, Tian Z, Li Y. ATG7 promotes bladder cancer invasion via autophagy-mediated increased ARHGDIB mRNA stability. Adv Sci (Weinh). 2021; 8(22):e2104365.","DOI":"10.1002\/advs.202104365"},{"key":"64170","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang S, Zhang J. Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis. Nat Cell Biol. 2022; 24(2):242-252.","DOI":"10.1038\/s41556-021-00814-7"},{"key":"64171","doi-asserted-by":"crossref","unstructured":"Zhang Y, Yu R, Li Q. SNHG1\/miR-556-5p\/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. J Cell Biochem. 2020; 121(2):1880-1889.","DOI":"10.1002\/jcb.29423"},{"key":"64172","doi-asserted-by":"crossref","unstructured":"Luo Z, Li X, Zhao Z, Yang X, Xiao S, Zhou Y. MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52. Oncol Lett. 2017; 13(3):1386-1392.","DOI":"10.3892\/ol.2016.5536"},{"key":"64173","doi-asserted-by":"crossref","unstructured":"The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489(7414):57-74.","DOI":"10.1038\/nature11247"},{"key":"64174","doi-asserted-by":"crossref","unstructured":"Whyte WA, Orlando DA, Hnisz D. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013; 153(2):307-319.","DOI":"10.1016\/j.cell.2013.03.035"},{"key":"64175","doi-asserted-by":"crossref","unstructured":"Hnisz D, Abraham BJ, Lee TI. Super-enhancers in the control of cell identity and disease. Cell. 2013; 155(4):934-947.","DOI":"10.1016\/j.cell.2013.09.053"},{"key":"64176","doi-asserted-by":"crossref","unstructured":"Wang Y, Song F, Zhang B. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 2018; 19(1):151.","DOI":"10.1186\/s13059-018-1519-9"},{"key":"64177","doi-asserted-by":"crossref","unstructured":"Wang X, Xu J, Zhang B. Genome-wide detection of enhancer-hijacking events from chromatin interaction data in rearranged genomes. Nat Methods. 2021; 18(6):661-668.","DOI":"10.1038\/s41592-021-01164-w"},{"key":"64178","doi-asserted-by":"crossref","unstructured":"Mallard C, Johnston MJ, Bobyn A. Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients. Cold Spring Harb Mol Case Stud. 2022; 8(1):a006157.","DOI":"10.1101\/mcs.a006157"},{"key":"64179","doi-asserted-by":"crossref","unstructured":"Jiang W, Zhou X, Li Z. Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin. Blood. 2018; 131(12):1325-1336.","DOI":"10.1182\/blood-2017-07-794875"},{"key":"64180","doi-asserted-by":"crossref","unstructured":"Gao M, Wang J, Rousseaux S. Metabolically controlled histone H4K5 acylation\/acetylation ratio drives BRD4 genomic distribution. Cell Rep. 2021; 36(4):109460.","DOI":"10.1016\/j.celrep.2021.109460"},{"key":"64181","doi-asserted-by":"crossref","unstructured":"Filippakopoulos P, Qi J, Picaud S. Selective inhibition of BET bromodomains. Nature. 2010; 468(7327):1067-1073.","DOI":"10.1038\/nature09504"},{"key":"64182","doi-asserted-by":"crossref","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013; 153(2):320-334.","DOI":"10.1016\/j.cell.2013.03.036"},{"key":"64183","doi-asserted-by":"crossref","unstructured":"Baxter EW, Mirabella F, Bowers SR. The inducible tissue-specific expression of the human IL-3\/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers. J Immunol. 2012; 189(9):4459-4469.","DOI":"10.4049\/jimmunol.1201915"},{"key":"64184","doi-asserted-by":"crossref","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Basinko A, De Braekeleer M. ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012; 36(8):945-961.","DOI":"10.1016\/j.leukres.2012.04.010"},{"key":"64185","doi-asserted-by":"crossref","unstructured":"Aldoss I, Clark M, Song JY, Pullarkat V. Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia. Hum Vaccin Immunother. 2020; 16(10):2341-2348.","DOI":"10.1080\/21645515.2020.1788299"},{"key":"64186","doi-asserted-by":"crossref","unstructured":"Bulaeva E, Pellacani D, Nakamichi N. MYC-induced human acute myeloid leukemia requires a continuing IL-3\/GM-CSF costimulus. Blood. 2020; 136(24):2764-2773.","DOI":"10.1182\/blood.2020006374"},{"key":"64187","doi-asserted-by":"crossref","unstructured":"Rossi Sebastiano M, Konstantinidou G. Targeting long chain Acyl-CoA synthetases for cancer therapy. Int J Mol Sci. 2019; 20(15):3624.","DOI":"10.3390\/ijms20153624"},{"key":"64188","doi-asserted-by":"crossref","unstructured":"Chen WC, Wang CY, Hung YH, Weng TY, Yen MC, Lai MD. Systematic analysis of gene expression alterations and clinical outcomes for long-chain acyl-coenzyme A synthetase family in cancer. PLoS One. 2016; 11(5):e0155660.","DOI":"10.1371\/journal.pone.0155660"},{"key":"64189","doi-asserted-by":"crossref","unstructured":"Gilliland DG, Tallman MS. Focus on acute leukemias. Cancer Cell. 2002; 1(5):417-420.","DOI":"10.1016\/S1535-6108(02)00081-8"},{"key":"64190","doi-asserted-by":"crossref","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022; 97(1):129-148.","DOI":"10.1002\/ajh.26352"},{"key":"64191","doi-asserted-by":"crossref","unstructured":"Francischetti IMB, Alejo JC, Sivanandham R. Neutrophil and eosinophil extracellular traps in Hodgkin lymphoma. Hemasphere. 2021; 5(9):e633.","DOI":"10.1097\/HS9.0000000000000633"},{"key":"64192","doi-asserted-by":"crossref","unstructured":"Guo J, Zheng Q, Peng Y. BET proteins: biological functions and therapeutic interventions. Pharmacol Ther. 2023; 243:108354.","DOI":"10.1016\/j.pharmthera.2023.108354"},{"key":"64193","doi-asserted-by":"crossref","unstructured":"Ianevski A, Giri AK, Aittokallio T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020; 48(W1):W488-W493.","DOI":"10.1093\/nar\/gkaa216"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284121\/76610","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284121\/77337","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11446\/76610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:44Z","timestamp":1794045944000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284121","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}